Commercial Colostrum Replacer Research Articles

Colostrum Replacement and Serum IgG Concentrations in Beef Calves Delivered by Elective Cesarean Section.

Assistance during calving and cesarean section (C-section) are important risk factors for the failure of transfer of passive immunity (FTPI) in beef calves, which increases the risk of morbidity and mortality in beef calves during the preweaning period. Colostrum replacement recommendations for beef calves, and especially for those delivered by C-section, are unavailable. The objective of this study was to determine whether or not colostrum replacement or supplementation with a commercially available product could increase serum IgG concentrations in beef calves delivered by elective C-section, compared to beef calves that nursed colostrum naturally. An elective C-section was performed in 32 pregnant beef cows and first-calf heifers. Immediately after delivery, newborn calves were randomly assigned to one of three different treatment groups. Group A calves (n = 7) were fed one packet of a commercial colostrum replacer (CR) product providing 60 g of IgG within 30 min of life. A second packet of the same CR was fed at 6 h of life. Group B calves (n = 13) were fed the same CR at the same frequency as group A; however, these calves were reunited with their dams after the second CR feeding to allow additional nursing of maternal colostrum. Group C calves (n = 12) were united with their dams immediately after surgery without colostrum intervention. Serum IgG levels at 48 h of life were greater in group C calves and in calves born to multiparous cows. Based on the results of this study, neither colostrum replacement nor supplementation result in higher serum IgG concentrations in beef calves delivered by elective C-section compared with natural nursing.

PSXIV-30 Effects of Vitamin/Mineral Supplementation During Gestation in Beef Heifers on Immunoglobulin Concentrations in Colostrum and Immune Responses in Naturally and Artificially Reared Calves

Abstract Two experiments were conducted to evaluate the impacts of feeding a vitamin/mineral supplement to beef heifers throughout gestation on concentrations of immunoglobulin (Ig) in colostrum and in calf serum 24 h after consumption of maternal colostrum (Exp. 1) or a colostrum replacement product (Exp. 2). Angus-based beef heifers [n = 72, initial body weight (BW) = 380.4 ± 50.56 kg] were managed in an individual feeding system and randomly assigned to a basal diet targeting gain of 0.45 kg·heifer-1·d-1 (CON; n = 36) or the basal diet plus 113 g·heifer-1·d-1 of a vitamin/mineral supplement (VTM; n = 36). For Exp. 1 treatments began at the time of artificial insemination (AI) to sexed semen, and heifers becoming pregnant after first service AI (CON, n = 14; VTM, n = 17) continued treatments throughout gestation. At calving, heifer calves were allowed to nurse their dams and remained alongside their dams until weaning. For Exp 2. non-pregnant heifers were rebred 60 d after initial dietary treatments began and continued treatments throughout gestation, with resultant heifer calves (CON, n = 7; VTM, n = 7) being removed from their dams at birth and receiving 1.5 L of colostrum replacer containing 150 g globulin protein via an esophageal feeder, followed every 12 h by 1.9 L of milk replacer. In both experiments samples of colostrum were collected after completely milking the rear-right quarter of the udder. Blood samples were collected from calves before (within 2 h of birth) and 24 h after colostrum consumption. Concentrations of IgG, IgM, and IgA were quantified in colostrum and serum via bovine radial immunodiffusion plates. Data for both experiments were analyzed for the effect of treatment using the MIXED procedure in SAS, with additional analysis of data from Exp. 1 using the CORR procedure to determine correlations among dam colostrum and calf serum Ig concentrations at 24 h. In both experiments, maternal treatment did not affect (P ≥ 0.21) concentrations of IgG, IgM, or IgA in colostrum at calving or in calf serum at 24 h. All calves from both experiments had undetectable concentrations of these respective immunoglobulins at birth. Concentrations of IgG at 24 h in calves that received maternal colostrum were 2,595.8 ± 535.38 mg/dL (Exp. 1), whereas those that received colostrum replacer were 1,610.6 ± 335.09 mg/dL (Exp. 2). Concentrations of IgG, IgM, and IgA were positively correlated (r ≥ 0.34; P ≤ 0.05) with concentrations of calf serum IgG, IgM, and IgA at 24 h after suckling. Our results suggest that maternal vitamin/mineral supplementation throughout gestation did not impact Ig concentrations in colostrum or the resultant serum Ig concentrations in calves either 24 h after suckling or after delivery of a commercial colostrum replacer.

Transfer and persistence of bovine immunoglobulins in lambs fed a colostrum replacer.

Colostrum-derived antibodies are crucial for the protection of newborn lambs from infectious diseases. Several colostrum replacer products that contain bovine antibodies are on the market. We investigated the absorption and persistence of bovine antibodies from a powdered colostrum replacer in newborn lambs. We tested a lamb colostrum replacer containing bovine serum in lambs that were separated from their dams at birth. Immunoglobulin G (IgG) uptake was analysed by ELISA, and the persistence of antigen-specific antibodies was analysed by parainfluenza 3 virus (PI-3) neutralisation assay. Serum antibody ELISA performed on days 1 and 14 revealed IgG levels of 17.9±2.8 and 27.5±2.5mg/ml, respectively. PI-3 antibodies derived from the colostrum replacer were present for 86.3±10.6 days. Antibodies derived from bovine serum protein delivered to lambs via a commercial colostrum replacer are readily absorbed and persist for months, suggesting that these products may offer adequate protection.

Performance of Hanwoo calves fed a commercial colostrum replacer versus natural bovine colostrum.

Supplying a sufficient amount of high-quality colostrum is a prevailing challenge in Hanwoo calf production systems. This study aimed to describe the efficiency of a lacteal-derived colostrum replacer versus natural bovine colostrum (from Holstein) fed to Hanwoo calves. Forty newborn Hanwoo calves (25 males and 15 females; 30.7 ± 3.15 kg body weight [mean ± standard deviation]) were blocked by sex and birth weight and fed either natural colostrum or a commercial colostrum replacer. Calves displayed a narrow difference in the evolution of body weight and structural body dimensions when they received a commercial versus natural colostrum. Minor differences existed in the starter and total dry matter consumption between calves fed natural or commercial colostrum. Although the colostrum source had no significant effects on days to first diarrhea (average of 7.6 days; p = 0.17), the duration of diarrhea was longer in natural colostrum-fed calves (3.2 vs. 4.5 days; p = 0.04). Consumption of natural colostrum resulted in greater mean serum immunoglobulin G (IgG) on day 2 (14.7 vs. 10.8 ± 0.92 mg/mL) and day 7 (8.21 vs. 5.12 ± 0.82 mg/mL) of calf life, resulting in a greater proportion of commercial colostrum-fed calves (50% vs. 15%; day 2) to experience failure of passive transfer of immunity (serum IgG < cutoff point of 10 mg/mL). Overall, growth rate, body frame development, and incidence of diarrheal disease were not different in both groups. These results suggested that the colostrum replacer product tested in this study could be an alternative to natural colostrum derived from Holstein cow in securing calf growth and health in Hanwoo calf-rearing operations.

Short communication: Variation in serum immunoglobulin G concentrations from birth to 112 days of age in Holstein calves fed a commercial colostrum replacer or maternal colostrum

Serum IgG concentrations in dairy calves change throughout their first weeks of life, peaking at 24 h and then steadily decreasing until calves begin to produce endogenous IgG. The objective of this study was to observe serum IgG dynamics from birth until 16 wk of life in calves fed either maternal colostrum (MC) or colostrum replacer (CR). A total of 44 Holstein calves were randomly assigned to 1 of the 4 colostrum treatments and followed throughout the study. Treatments consisted of feeding high-quality MC, low-quality MC supplemented with CR, or 1 of 2 distinct levels of IgG concentration from CR. Overall, the interaction between type of colostrum fed and sampling time was significant. Individual differences for this effect were found at d 1, 7, 14, 21, 28, and 98, while the other time points were not different.

Comparison of immunoglobulin G absorption in calves fed maternal colostrum, a commercial whey-based colostrum replacer, or supplemented maternal colostrum

Successful passive transfer of antibodies in neonatal calves can be achieved by feeding an adequate quantity and quality of maternal colostrum (MC) or colostrum replacer (CR). An alternative could be feeding low-quality maternal colostrum (LMC) with added IgG from a CR. The objective of this study was to determine if a commercial whey-based CR product containing low levels of casein (Premolac PLUS Bovine IgG; Zinpro Corporation, Eden Prairie, MN) fed to replace MC or supplement LMC could lead to adequate serum IgG levels and apparent efficiency of absorption (AEA) in neonatal dairy calves. Holstein calves (n = 20 per treatment) were separated from their dam after birth and randomly assigned to be fed 3.79 L of MC (106 g/L of IgG; 401 g of IgG fed), LMC (30 g/L IgG) supplemented with CR (41 g/L IgG; 154 g of IgG total fed; LMC-CR), or 1.3 L of 1 of 2 levels of CR (110 or 150 g of IgG fed; CR-110 or CR-150) within 1.5 h of birth. Colostrum was obtained from the first (MC) or second and third milkings (LMC) of cows from Pennsylvania State University dairy and pooled by source into large batches. Blood samples were taken from calves before colostrum feeding and 24 h after birth and were analyzed for serum total protein, total IgG, hematocrit, and Brix percentage. Calves fed MC had higher 24-h IgG values (means ± SEM) than calves fed LMC-CR (27.04 ± 1.07 vs. 22.33 ± 1.08 mg/mL, respectively). Feeding 150 g of IgG from CR led to higher 24-h serum IgG values than feeding 110 g of IgG (16.90 ± 1.09 vs. 12.79 ± 1.08 mg/mL). Serum IgG levels were different between the CR-fed calves and the calves fed LMC-CR and MC, but all had average values >10 mg/mL IgG. Calves fed LMC-CR had greater AEA than calves fed MC (54.58 ± 2.39 vs. 24.38 ± 2.36%, respectively). Among calves fed CR-110 or CR-150, AEA did not differ. Serum total protein and Brix percentage had strong correlations with actual IgG values across the entire study. We found no differences in average daily gain or health variables measured, and no differences in final hip width, withers height, or body weight for calves fed MC, LMC-CR, CR-150, or CR-110. These results indicate that CR can be fed successfully as an alternative to MC or as a supplement to colostrum with low IgG.

Short communication: Blood mineral and gas concentrations of calves born to cows fed prepartum diets differing in dietary cation-anion difference and calcium concentration

Eighty-two multiparous Holstein cows were fed diets differing in dietary cation-anion difference (DCAD) and Ca concentrations in a randomized block design experiment beginning 4 wk before anticipated calving to determine the effects on colostrum yield and quality and acid-base balance and mineral status of newborn calves. Treatments were arranged as a 2 × 2 factorial to provide 2 DCAD [-22 mEq/100 g of dry matter (NEG) or -3 mEq/100 g of dry matter (NEU)] and 2 supplemental Ca concentrations (1.3 or 1.8% of dry matter). After calving, cows were milked within 2 to 8 h and colostrum yield was recorded. Calves were fed 200 g of IgG of a commercial colostrum replacer within 4 h of birth. No differences were observed in birth weight or dystocia score among treatments, which averaged 42.7 kg and 1.12, respectively. Colostrum yield was not different among treatments and averaged 8.75 kg. Colostrum quality, as measured using a Brix refractometer, was not affected by DCAD but was higher for 1.3% compared with 1.8% Ca: 21.58% and 19.87%, respectively. Colostrum IgG concentrations were higher for NEG compared with NEU and for 1.3% compared with 1.8% Ca. No differences were observed in concentrations of serum IgG, Ca, P, K, Cl, anion gap, or whole-blood pH, partial pressure of O2, or SO2 of calves among treatments. Serum Mg and lactate concentrations were higher and CO2 tended to be lower for calves born to cows fed 1.3% compared with 1.8% Ca. Interactions of DCAD and Ca were observed for serum Na and Cl, which were higher for NEU-1.3% Ca and NEG-1.8% Ca compared with NEU-1.8% Ca and NEG-1.3% Ca. Whole-blood partial pressure of CO2, and HCO3 exhibited an interaction of DCAD and Ca and tended to be lower for NEU-1.3% Ca and NEG-1.8% Ca compared with NEU-1.8% Ca and NEG-1.3% Ca. Results of this trial indicate that feeding prepartum diets with 1.8% compared with 1.3% supplemental Ca reduced colostrum quality and serum concentrations of Mg and lactate in calves immediately after birth. Feeding NEG supported higher colostrum IgG concentrations. Blood mineral concentrations and blood gas balance tended to differ, but the effects were not consistent across DCAD and Ca.

Preweaned heifer management on US dairy operations: Part II. Factors associated with colostrum quality and passive transfer status of dairy heifer calves

Passive transfer of immunity is essential for the short- and long-term health of dairy calves. The objective of this study was to evaluate factors associated with colostrum quality and passive transfer status of US heifer calves. This study included 104 operations in 13 states that participated in the calf component of the National Animal Health Monitoring System's Dairy 2014 study. This 18-mo longitudinal study included 1,972 Holstein heifer calves from birth to weaning. Multivariable mixed linear regression models were selected using backward elimination model selection after univariate screening to determine which factors were associated with colostrum IgG and serum IgG concentrations. The mean colostrum IgG concentration was 74.4 g/L with 77.4% of colostrum samples having IgG concentrations >50 g/L. The final model for colostrum IgG included colostrum source and a categorized temperature-humidity index value (cTHI) for the month before calving. Mean colostrum IgG concentrations were highest for dams in third and higher lactations (84.7 g/L) and lowest for commercial colostrum replacers (40.3 g/L). Colostrum IgG concentrations were highest for cTHI ≥70 (72.6 g/L) and lowest for cTHI <40 (64.2 g/L). The mean serum IgG concentration was 21.6 g/L, with 73.3% of calves having serum IgG concentrations >15 g/L. The final model for serum IgG concentration included region, heat treatment of colostrum, colostrum source, timing to first feeding, volume of colostrum fed in the first 24 h, age of the calf at blood sampling, and colostrum IgG concentration. Mean serum IgG concentrations were highest for calves that received colostrum from first-lactation dams (25.7 g/L) and lowest for calves fed commercial colostrum replacer (16.6 g/L). Serum IgG concentrations were higher for calves fed heat-treated colostrum (24.4 g/L) than for calves fed untreated colostrum (20.5 g/L). Serum IgG concentration was positively associated with the volume of colostrum fed in the first 24 h and colostrum IgG concentration, and negatively associated with the number of hours from birth to colostrum feeding and age (days) at blood collection. Dairy producers should be encouraged to measure the quality of colostrum before administering it to calves and to measure serum IgG or a proxy such as serum total protein or Brix to evaluate passive immunity and colostrum management programs.

Addition of gut active carbohydrates to colostrum replacer does not improve passive transfer of immunoglobulin G in Holstein dairy calves

The primary objective of this study was to investigate the effects of supplementing a commercial colostrum replacer (CR) with gut active carbohydrates (GAC) on passive transfer of IgG in commercial dairy calves. A secondary objective was to evaluate the effect of treatment on preweaning health and growth. A total of 240 newborn Holstein dairy calves on a commercial dairy farm were enrolled in this study. Newborn heifer and bull calves were weighed and then randomly assigned to either the treated group [GAC: 30g of GAC mixed into 1.5 doses (150g of IgG) of commercial colostrum replacer; n=119] or the control group [CON: 1.5 doses (150g of IgG) of CR; n=121]. The assigned CR treatment was fed within 3.5h of birth using an esophageal tube feeder. Venous blood samples were collected at 0 and 24h of age and used to measure serum IgG (mg/mL) and serum total protein (g/dL) concentrations and to estimate the apparent efficiency of absorption of IgG (%). The 129 heifers calves enrolled (CON=60; GAC=69) were also followed until weaning to assess the effect of GAC addition on preweaning health and growth. Multivariable linear regression showed that the addition of GAC to CR did not influence passive transfer of IgG, as measured by apparent efficiency of absorption at 24h of age (CON=54.0 vs. GAC=54.3%), serum IgG (CON=20.3 vs. GAC=20.2mg/mL), and serum total protein (CON=5.69 vs. GAC=5.68g/dL). Although study sample sizes were not originally derived to evaluate health outcomes, treatment had no effect on weight gain or incidence of health events (diarrhea, pneumonia, mortality) for heifer calves between birth and 7 wk of age.

Effect of adding gut active carbohydrates to colostrum replacer on passive transfer of immunoglobulin G in Holstein dairy calves

Early feeding of a sufficient quantity of high-quality colostrum is the key to good colostrum management and obtaining sufficient passive transfer of immunity in newborn calves. Various products have been added to colostrum to evaluate their potential for improving passive transfer of colostral immunoglobulins (lg). Research findings suggest that maternal colostrum supplemented with gut-active carbohydrates (GAC) or mannan-oligosaccharides resulted in higher serum IgG concentrations in young mammals. The aim of this study was to investigate the effects of supplementing a commercial colostrum replacer (CR) with GAC on the serum IgG concentration and preweaning performance of dairy calves in a commercial farm setting.

EVALUATION OF A COMMERCIAL BOVINE COLOSTRUM REPLACER FOR ACHIEVING PASSIVE TRANSFER OF IMMUNITY IN SPRINGBOK CALVES (ANTIDORCAS MARSUPIALIS)

Failure of passive transfer (FPT) occurs in ruminant species when there is inadequate absorption of immunoglobulins from the colostrum. In zoologic establishments, FPT can be a common occurrence in hand-raised ruminant neonates fed insufficient amounts of colostrum replacer (CR) and/or poor-quality CR. The goals of this study were to investigate the efficacy of a commercial bovine CR at achieving adequate passive transfer of immunity and evaluate tests to assess FPT in nondomestic ruminant species. In the past several years, research in dairy calves has shown that passive transfer rates can be dramatically improved if the CR dose is doubled. The treatment group (n = 10) consisted of springbok (Antidorcas marsupialis) calves fed Land O'Lakes bovine commercial CR at a dose of > or = 4.68 g of immunoglobulin G (22 g of CR powder) per kilogram of animal's body weight divided into five feedings over 24 hr. The control group (n=7) consisted of calves that nursed from their dams. This study reported no significant difference between the proportion of calves with adequate passive transfer in the treatment (80%) and control (71%) groups (P= 1.00). Morbidity and mortality rates until weaning were 0% in both groups. The study also determined the sensitivity and specificity values (n = 37) for five serum tests (y-glutamyl-transferase [GGT], globulin, glutaraldehyde coagulation [GC], sodium sulfite turbidity test, and total protein) used to determine passive transfer status in springbok calves. This study recommends the following serum tests and cutoff ranges for determining FPT in springbok calves: globulin < or = 1.85 mg/dl, GGT < or = 228.5 IU/ L, and GC > or = 28 min.

Comparison of serum concentrations and duration of BVDV 1, BVDV 2, BHV-1, BRSV, and PI3 virus-neutralizing antibodies in calves fed maternal colostrum or a colostrum replacer at birth

Providing newborn calves with high concentrations of neutralizing antibodies through colostrum is a key management strategy for the reduction of respiratory disease caused by BVDV, BHV-1, BRSV, and PI3 in young calves. When maternally-derived immunity decays, calves become susceptible to acute viral infection and disease. Duration of maternally-derived immunity is dependent on the amount of neutralizing antibodies absorbed from colostrum. Feeding a commercial colostrum replacer is an alternative to provide passive immunity to neonatal calves when availability of maternal colostrum is compromised. The ability of colostrum replacers to provide neonatal calves with an adequate concentration and duration of specific virus-neutralizing antibodies against common respiratory viruses has not been described. The objective of this study was to compare the total serum concentration and duration of BVDV, BHV-1, BRSV and PI3 virus neutralizing antibodies in calves fed maternal colostrum (MC) or a commercial colostrum replacer (CR) at birth.

Effect of a plasma-derived colostrum replacement feeding program on adult performance and longevity in Holstein cows

To evaluate longevity, milk production, and breeding performance in adult Holstein cows fed either a plasma-derived commercial colostrum replacer (CR) or raw bovine maternal colostrum (MC) at birth. Randomized controlled clinical trial. 497 heifer calves born in 12 commercial dairies located in Minnesota and Wisconsin. All calves were separated from their dams within 30 to 60 minutes after birth and systematically assigned to be fed either MC (control group [n = 261 calves]) or CR (treatment group [236]). Calves were observed from birth up to adulthood (approx 54 months old), during which time death and culling events plus milk yield and breeding performance data were collected. Time to death, time to culling, time to death or culling combined, time to first calving, and time to conception intervals were evaluated by use of proportional hazards survival analysis models. Number of times inseminated per conception and lifetime milk yield (up to 54 months old) were evaluated by use of general linear models. Cows fed CR as calves at the time of birth were no different than cows fed MC as calves with respect to overall risk of death, culling, or death or culling combined (from birth to 54 months of follow-up and from first calving to 54 months old); lifetime milk yield; and breeding performance. No difference was detected in overall risk of death or culling, milk production, or reproductive performance between cows fed CR and those fed MC as calves at birth.

Efficacy of feeding plasma-derived commercial colostrum replacer for the prevention of transmission of Mycobacterium avium subsp paratuberculosis in Holstein calves

To estimate the relative risk of paratuberculosis (Johne's disease [JD]) in calves fed a plasma-derived colostrum-replacement (CR) product versus raw bovine maternal colostrum (MC). Randomized controlled clinical trial. 497 heifer calves born in 12 JD-endemic commercial Holstein dairy farms located in Minnesota and Wisconsin. Every calf was separated from its dam within 30 to 60 minutes after birth and systematically assigned to be fed raw bovine MC (control group, n = 261 calves) or CR (treatment group, 236 calves). The calves were monitored to adulthood and tested for Mycobacterium avium subsp paratuberculosis (MAP) infection by use of an ELISA to detect serum antibodies against MAP and bacterial culture for MAP in feces at approximately 30, 42, and 54 months of age. Weibull regression models were used to evaluate the effect of feeding CR (vs raw bovine MC) on the risk of developing JD infection. Calves fed CR at birth were less likely (hazard ratio = 0.559) to become infected with MAP (as determined by use of an ELISA, bacterial culture, or both diagnostic tests), compared with the likelihood for calves fed MC at birth. This study revealed that feeding CR reduced the risk of developing MAP infection in Holstein calves born in JD-endemic herds, which implied that feeding raw bovine MC may be a source of MAP for calves. Plasma colostrum-replacement products may be an effective management tool for use in dairy herds attempting to reduce the prevalence of JD.

Improving passive transfer of immunoglobulins in calves. I: Dose effect of feeding a commercial colostrum replacer

The objective of this study was to describe the effects of feeding 1 or 2 doses of a commercially available colostrum-derived colostrum replacer (CR) on passive transfer of immunoglobulins (Ig) in newborn dairy calves, including IgG, IgG1, IgG2, IgA, and IgM. Newborn calves were removed from the dam before suckling and randomly assigned to 1 of 3 treatment groups: group 1 were fed 1 package (100g of IgG) of CR product, group 2 was fed 2 packages (200g of IgG) of the same CR product, and group 3 was fed 3.8L of maternal colostrum. All colostrum treatments were fed using an esophageal tube feeder within 2h of birth. Blood samples collected before colostrum feeding and at 24h of age were tested for serum total protein and Ig concentrations. Mean 24-h serum total protein (TP) and IgG concentrations were significantly lower for calves in group 1 (n = 24; TP = 4.9 g/dL, IgG = 9.6mg/mL) compared with calves in groups 2 or 3. There was no difference in 24-h serum TP or IgG concentrations between calves in group 2 (n = 23; TP = 5.5 g/dL, IgG = 19.0mg/mL) and calves in group 3 (n = 22; TP = 5.7 g/dL, IgG = 20.7mg/mL). Fifty-four, 100, and 91% of calves in groups 1, 2 and 3 achieved acceptable passive transfer (24-h serum IgG ≥10mg/mL), respectively. Statistically significant but numerically small differences existed between calves in groups 2 and 3 for some 24-h serum Ig classes and subclasses (mean serum concentrations of IgG2, IgA, IgM) and for the relative percentages of Ig classes and subclasses (IgA, IgM, and IgG as a percentage of total Ig; IgG1 and IgG2 as a percentage of total IgG).

Effect of Plasma-derived Colostrum Replacer Feeding Programs for Prevention of Mycobacterium avium subspecies Paratuberculosis in Dairy Calves

The objective of this study was to estimate the relative risk of Mycobacterium avium subspecies paratuberculosis (MAP) infection in calves fed a plasma-derived commercial colostrum replacer (CR) vs bovine maternal colostrum (MC) after birth.

Impact of Irradiation and Immunoglobulin G Concentration on Absorption of Protein and Immunoglobulin G in Calves Fed Colostrum Replacer

The objective of this study was first to evaluate whether irradiation treatment of a commercial colostrum replacer (CR) affected acquisition of passive immunity. If the irradiation treatment negatively affected the acquisition of passive immunity, the second objective was to evaluate whether an increased total IgG mass, in a single feeding of CR derived from bovine serum fractions, could compensate for this effect. Acquisition of passive immunity was assessed by 24-h serum IgG levels, serum protein levels, apparent efficiency of absorption (AEA) of IgG, and the ability to prevent failure of passive transfer (FPT) in day-old dairy calves fed a single feeding of CR. Single-dose packs of CR were sent to a commercial irradiation facility for electron-beam irradiation at 3 to 7kGy (low irradiation) or 15 to 20kGy (high irradiation). Fifty-six Holstein, Jersey, or crossbred calves were randomly assigned to 1 of 5 treatments: 1) 130g of IgG (460g of CR), no irradiation; 2) 130g of IgG (460g of CR), low irradiation; 3) 160g of IgG (518g of CR), low irradiation; 4) 190g of IgG (575.4g of CR), low irradiation; and 5) 130g of IgG (460g of CR), high irradiation. All CR were reconstituted in water and mixed in a household blender to a constant solids concentration of 18.7%. Increasing doses of irradiation (130g of Ig with no, low, or high irradiation) resulted in a linear decrease in 24-h serum IgG and AEA of IgG, and increased the percentage of calves with FPT. Increasing the IgG mass in the CR (130, 160, and 190g of Ig with low irradiation) resulted in a linear increase in 24-h serum IgG and serum total protein levels, and a linear decrease in AEA of IgG. There was no effect of increasing the mass of IgG fed on the percentage of calves with FPT. The correlation between serum IgG and serum total protein at 24h was positive; however, at 24h the irradiation treatments reduced the serum IgG-to-serum total protein ratio. In this study, CR isolated from bovine serum, providing 130g of IgG in the first feeding and receiving either no irradiation or a low irradiation treatment, was sufficient to prevent FPT in calves.

Effect of Feeding One or Two Doses of a Colostrum-Derived Commercial Colostrum Replacer on Passive Transfer of Immunoglobulin Gin Newborn Dairy Calves

Colostrum is the single most important management factor determining calf health and survival. Calves experiencing successful passive transfer of colostral immunoglobulins (serum IgG &gt; 10.0 mg/ml) have improved preweaning health and survival, improved growth rate and feed efficiency, reduced age at onset of puberty, reduced age at first calving, and improved first and second lactation milk production. Unfortunately, many producers continue to suffer significant losses related to poor colostrum management. Factors affecting the success of a colostrum management program include 1) Quality of colostrum fed, 2) quantity of colostrum fed, 3) quickness of providing the first colostrum feeding and 4) cleanliness of colostrum (i.e. bacterial contamination). Use of commercial colostrum replacement products may offer multiple advantages, including consistent quality, convenience, and cleanliness. However, it is important to evaluate the ability of commercially available colostrum replacement (CR) products to achieve successful passive transfer of immunoglobulin G (lgG) in calves managed under field conditions. The objective of this study was to describe passive transfer of lgG in newborn calves fed one or two doses ( 100 gm IgG or 200 g IgG) of a commercial colostrum-derived colostrum replacement (CR: Land O'Lakes Colostrum Replacement®, Land O'Lakes Animal Milk Products, St. Paul, MN) or 4 quarts of maternal colostrum (MC).

Passive Transfer of Immunoglobulin G and Preweaning Health in Holstein Calves Fed a Commercial Colostrum Replacer

The objective of this study was to describe passive transfer of IgG and preweaning health in newborn calves fed a commercially available plasma-derived colostrum replacement (CR) product or maternal colostrum (MC). Twelve commercial Holstein dairy farms enrolled singleton newborn heifer calves to be fed fresh MC (n=239 calves) or one dose of CR containing 125g of Ig (n=218 calves) as the first colostrum feeding. For 7 of these farms that routinely provided a second feeding of 1.9L of MC to their calves 8 to 12h after the first colostrum feeding, calves assigned to the CR treatment group were offered a second feeding consisting of 1.9L of commercial milk replacer supplemented with one dose of a commercially available plasma-derived colostrum supplement, containing 45g of Ig per dose, 8 to 12h after the first colostrum feeding. A blood sample was collected from all calves between 1 to 8 d of age for serum IgG and total protein (TP) determination, and records of all treatment and mortality events were collected until weaning. Serum IgG and TP concentrations were significantly higher in calves fed MC (IgG=14.8±7.0mg/mL; TP=5.5±0.7g/dL) compared with calves fed CR (IgG=5.8±3.2mg/mL; TP=4.6±0.5g/dL). The proportion of calves with failure of passive transfer (serum IgG <10.0mg/mL) was 28.0 and 93.1% in the MC and CR treatment groups, respectively. Though a trend was present, the proportion of calves treated for illness was not statistically different for calves fed MC (51.9%) vs. CR (59.6%). Total number of days treated per calf (MC=1.7; CR=2.0), treatment costs per calf (MC=$10.84; CR=$11.88), and proportion of calves dying (MC=10.0%; CR=12.4%) was not different between the 2 colostrum treatment groups. The mean serum total protein concentration predictive of successful passive transfer (serum IgG=10mg/mL) was 5.0g/dL in calves fed MC or CR. Long-term follow-up of these calves (to maturity) is ongoing to describe the effects of feeding CR on longevity, productivity, risk for Johne's disease, and economics.

Preliminary studies on the bacterial flora of faeces taken from foals, from birth to twelve weeks. Effect of the oral administration of a commercial colostrum replacer

Preliminary studies on the bacterial flora of faeces taken from foals, from birth to twelve weeks. Effect of the oral administration of a commercial colostrum replacer